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Circular proteins, defined as head-to-tail cyclized polypep-
tides originating from ribosomal synthesis, represent a novel
class of natural products attracting increasing interest. From a
scientific point of view, these compounds raise questions of
where and why they occur in nature and how they are formed.
Froma rational point of view, these proteins and their structural
concept may be exploited for crop protection and novel phar-
maceuticals. Here, we review the current knowledge of three
protein families: cyclotides and circular sunflower trypsin
inhibitors from the kingdom of plants and the Amanita toxins
from fungi. A particular emphasis is placed on their biological
origin, structure, and activity. In addition, the opportunity for
discovery of novel circular proteins and recent insights into
their mechanism of action are discussed.
The destiny of proteogenic amino acid building blocks is to
be joined into chains via their N- and C-terminal ends. Hence,
one could argue that linear proteins with free termini are unfin-
ished, whereas head-to-tail cyclized proteins with a full circle of
amide bonds represent the only “complete” polypeptides.
Circular proteins have now been reported from all kingdoms
of life. This minireview focuses on plant and fungal circular
proteins of ribosomal origin, i.e. sequences that are genetically
encoded. Currently, three such classes are known: theAmanita
toxins from fungi and the cyclotides and sunflower trypsin
inhibitors from plants. The sources, genes, and protein struc-
tures of these proteins are summarized in Fig. 1. Their diverse
origin and characteristics highlight that nature has foundmany
ways of producing circular proteins, suggesting that more
classes are yet to be discovered.
Fungal Circular Proteins
Amatoxins and phallotoxins are themajor toxins of the lethal
mushrooms of the family Amanitaceae (1, 2). Specifically, these
toxins have been isolated from Amanita species from the sec-
tion Phalloidae (including the death cap (Amanita phalloides)
and the destroying angel (Amanita virosa)). The existence of
“alkaloid-like” toxic compounds in Amanita has been known
for almost two centuries, but their ribosomal origin was estab-
lished only recently (3). Presently, the amatoxins constitute a
suite of nine different 8-residue long circular peptides; the
structure of -amanitin is shown in Fig. 1a. All nine amatoxins
are post-translationally modified products of the protein
sequence encoding -amanitin or -amanitin. The post-trans-
lational process incorporates hydroxylations and an unusual
cross-link between a Trp and a Cys residue via a sulfoxide. The
phallotoxins are seven-membered protein circles that originate
from phallacidin or phalloidin protein sequences. In analogy to
amatoxins, they are stabilized by an extra cross-link; in this
case, a sulfide links the Trp and Cys residues.
Amatoxins and phallotoxins share their genetic origin in that
they are both products of the same gene family,MSDIN (3). The
AMA1 and PHA1 genes, which encode -amanitin and phallo-
idin, respectively, are expressed as 33- and 32-residue linear
precursor proteins, respectively. All members of the family
contain Pro residues N- and C-terminal of the mature
sequence, which are likely required for the release and cycliza-
tion of the mature toxin domain by a prolyl oligopeptidase (4).
Although genetics predicted 19 mature toxin sequences, only
four of these have been found in modified versions at the pro-
tein level (- and -amanitin, phallacidin, and phalloidin).
Those four sequences are the only ones containing Cys and Trp
residues and thus are the only members that can contain the
sulfoxide/sulfide cross-link. This suggests that the cross-link is
important either for the stability and longevity or for the folding
and cyclization of the peptides. However, several additional
Amanita toxins lacking the link have been found at the protein
level, but in contrast, the biosynthetic origin of these is
unknown. For example, this is the case for antamanide (cyclo-
(VPPAFFPPFF)), which contains only unmodified proteogenic
amino acids and is likely also of ribosomal origin from a gene
that still awaits discovery.
The amatoxins and phallotoxins are highly potent toxins. In
fact, amatoxin-containing species are responsible for 90% of
all fatal cases of mushroom poisoning (2). The fact that toxins
survive the digestive tract is testament to the stability afforded
by their cross-linked structure. The LD50 in humans for
-amanitin is 0.1 mg/kg, meaning that a single mushroom
can contain a lethal dose. The drastic effect of these compounds
is mediated through inhibition of transcription by specific
interactions with RNA polymerase II (5) (Fig. 2a). This binding
relies heavily on the post-translational decoration, with the
constrained Trp and hydroxyl groups forming close interac-
tions with the protein (5). Polymerases from different organ-
isms show varying degrees of sensitivity, and the potency of the
different amatoxins varies. The latter is illustrated by the LD50
values in mice: -amanitin has an LD50 value 0.3 mg/kg, but
amanullin, which lacks two hydroxyl groups, is two orders of
magnitude less toxic. The phallotoxins bind to F-actin to stabi-
lize the structure of assembled filaments (1). Phalloidin has thus
become a valuable molecular tool used for cellular and molec-
ular imaging when conjugated with fluorescent labels (6).
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FIGURE 2.Mechanisms of action. a, the crystal structure (Protein Data Bank code 3CQZ) shows -amanitin binding deep in the substrate-binding channel of
the largemultisubunit RNApolymerase II.b, SFTI-I binds tightly to the trypsin active site (ProteinData Bank code 1SFI). A number of studies havedemonstrated
the ability of cyclotides to interact with and disrupt biological membranes. c, schematic model of the interaction between cycloviolacin O2 and E. coli inner
membranes comprising phosphatidylglycerol (PG) and PE lipids. Accumulation of cyclotides, driven by electrostatic interaction ((i)), leads to membrane
thinning ((ii)) through selective binding to and extraction of PE lipids ((iii)) and increased flip-flop of PE lipids from the inner leaflet.
FIGURE 1. Sources, genes, and structures of circular proteins from plants and fungi. a, amatoxins are embedded in 30-amino acid long precursors.
Structures highlight the Cys-Trp bond and hydroxylations. b, albumin is hijacked for SFTI-1/SFT-L1 biosynthesis. The -sheet structure is stabilized by one
disulfide bond. Alb. s.u., albumin subunit. c, gene expression differs between cyclotide-expressing plant families. In Fabaceae, the gene is expressed within an
albumin. Violaceae and Rubiaceae share the features of an endoplasmic reticulum (ER) signal, followed by the Pro region, the N-terminal repeat (NTR), the
mature cyclotide domain, and a conserved tail region. Structures demonstrate cyclotide subfamilies and the positions of the sequence loops.
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SunflowerTrypsin Inhibitors—Isolated from sunflower (Heli-
anthus annuus) seeds, sunflower trypsin inhibitor-1 (SFTI-1)4
is a 14-residue cyclic peptide with subnanomolar inhibitory
activity against trypsin (7). The three-dimensional structure of
SFTI-1 reveals a well defined and rigid arrangement of two
antiparallel -strands that are stabilized by a single disulfide
bond and an extensive internal network of hydrogen bonds (8).
SFTI-1 forms a tight binding complexwith bovine trypsin by an
extended -sheet across active site residues P1–P4 (trypsin/
SFTI-1 Ki 0.1 nM) (Fig. 2b) and shares a common conforma-
tion in its active loop with other serine proteases of the Bow-
man-Birk inhibitor family. The backbone circle in SFTI-1 is
completed by a hairpin loop, which is termed the secondary
loop.
The contributions made by both the circular backbone and
the disulfide bond to the SFTI-I structure and activity have been
examined. Synthetic disulfide-deficient but cyclic SFTI-1 is
more flexible and less active than native SFTI-1, indicating a
greater loss in entropy in binding to trypsin compared with
native SFTI-1 (9). In contrast, the potency andhydrolysis rate of
acyclic SFTI-1 opened between Asp14 andGly1 are only slightly
reduced relative to cyclic SFTI-1. The cyclic and acyclic SFTI-1
structures are essentially identical, with the exception of the
loss of one hydrogen bond in the secondary loop in acyclic
SFTI-1 (8). Thus, the disulfide bond, together with hydrogen
bonds in the secondary loop, provides enough stability tomain-
tain the -sheet structure and, in turn, the rigidity of the bind-
ing loop (9). However, removal of both the disulfide and the
circular backbone results in complete loss of trypsin inhibitory
activity and disruption of the native-like fold (9). An alanine
scan has also shown that the scaffold is tolerant to sequence
modifications, with all non-cysteine residues able to be
replaced without losing structural stability, with the exception
ofAsp14, which is involved in a hydrogen bonding network (10).
Recently, it became evident that SFTI-1 is derived from a
151-residue albumin seed storage protein and that it is also
found in other Helianthus species (11). Transgenic experi-
ments indicate that an asparaginyl endopeptidase, responsible
for processing for the albumin, releases and cyclizes SFTI-1
(11). Subsequently, it was shown that another 12-residue cyclic
peptide termed SFT-L1 (or SFTI-Like1) is located within the
spacer region of another albumin gene. SFT-L1 currently rep-
resents the smallest plant circular protein known.
Cyclotides—The unique cyclotide structure was first
described in the mid-1990s when the NMR spectroscopy anal-
ysis of kalata B1 fromOldenlandia affinis revealed the presence
of both a circular peptide backbone and a so-called cystine knot,
inwhich three conserved disulfide bonds are arranged such that
one disulfide penetrates an embedded ring formed by the two
other disulfides and their interconnecting backbone. Further
discoveries established them as a family, and the term cyclo-
tides (cyclo-peptides) was coined (12). Current indications
point to cyclotides being one of the largest protein families
known, with tens of thousands of members (13).
Structural Features—A typical cyclotide consists of 30
amino acids, with only 6 strictly conserved residues, the cys-
teines. The residues between each cysteine are defined as loops
(1–6) and, in contrast, are generally highly interchangeable
(Fig. 1c). The cystine knot, in combination with the additional
cross-bracing afforded by the circular backbone, locks the chain
into the cyclic cystine knot motif, which renders the structure
as close to indestructible as a proteinaceous substance is ever
likely to be. Kalata B1 in its oxidized form is fully resistant to all
proteases tested, as well as thermal denaturation by boiling or
unfolding by chaotropic agents (14). Numerous cyclotides have
been structurally characterized, primarily by NMR spectros-
copy (e.g.Ref. 15) but also by x-ray crystallographic studies (16).
These studies have revealed a number of conserved features.
The cyclotide backbone is tightly folded and comprises a large
number of intramolecular hydrogen bonds (15). These bonds
stabilize elements of secondary structure, including a-hairpin
and, in the bracelet cyclotides, a short 310 helix, which are con-
nected by a series of well defined tight turns. The division of
cyclotides into two subfamilies, Möbius and bracelets, is based
on the former comprising a conserved conformation of the turn
in loop 5, which includes a cis-Pro bond creating a conceptual
twist of the peptide backbone (12).
A Glu residue in loop 1 is conserved throughout the family,
with only a single exception among the200 cyclotides known
(17). ThisGlu has been found to coordinate a network of hydro-
gen bonds to amide protons in loop 3 via its carboxyl group (15,
18). This interaction is clearly a prerequisite for both structure
and function of cyclotides, as replacement or modification
results in both a compromised structure and significantly
reduced bioactivity (19, 20).
The internal core of the cyclotide proteins is almost fully
occupied by the conserved cystine knot, which gives the cyclo-
tides a peculiar feature, namely a large number of surface-ex-
posed hydrophobic residues. As a result, cyclotides typically
have a highly amphiphilic character.
Occurrence of Cyclotides—Despite the high predictions for
the number of cyclotides present in nature, to date, they have
been found only in a few plant families, primarily in Violaceae
and Rubiaceae. Although Rubiaceae is a large plant family, cy-
clotides are found only in aminority of species (13). In contrast,
cyclotides have been found in all Violaceae species screened;
hence, the family can be regarded as a rich source of cyclotides
(21). Recently, cyclotides were also reported in one species of
the Fabaceae family, Clitoria ternatea (22). Furthermore, two
cyclic cystine knot peptides have been described inMomordica
cochinchinensis of the Cucurbitaceae family (23), but these
trypsin inhibitors are more closely related to linear squash pro-
tease inhibitors than other cyclotides. The four cyclotide-bear-
ing plant families are phylogenetically distant, which suggests
that their distribution in the plant kingdom is wider than cur-
rent knowledge suggests.
Biological Activities and Mechanism of Action—Numerous
biological activities havebeen reported for cyclotides, e.g.utero-
tonic, hemolytic, inhibition of neurotensin action, anti-HIV,
cytotoxic, molluscicidal, anthelmintic, and antifouling effects
(24). Cyclotides are also active against different bacteria (25, 26)
and the insect larvae Helicoverpa punctigera and Helicoverpa
4 The abbreviations used are: SFTI-1, sunflower trypsin inhibitor-1; PE,
phosphatidylethanolamine.
MINIREVIEW: Circular Proteins from Plants and Fungi
AUGUST 3, 2012•VOLUME 287•NUMBER 32 JOURNAL OF BIOLOGICAL CHEMISTRY 27003









armigera (27). Insecticidal and antimicrobial activities suggest
that the native role of cyclotides in plants is as components of
the innate defense system (28). Anumber of studies have shown
that cyclotides interact with membranes. For example, cyclo-
tides insert into micelles (29) and disrupt liposomes (30), bac-
terialmembranes (31, 32), andmembranes of enveloped viruses
(31).
In our view, the interaction between cyclotides and themem-
brane has three components: (i) electrostatic interactions
between charged residues and charged lipid headgroups, (ii)
insertion into the membrane governed by the surface-exposed
hydrophobic patch, and (iii) a specific interaction between the
cyclotide and a lipid headgroup (Fig. 2c). Importantly, the con-
tribution of each of these components to the overall affinity
differs depending on the cyclotide in question and the compo-
sition of the targeted membrane, explaining differences in the
bioactivity observed for different cyclotides in different assays.
(i) Electrostatic interactions between cationic peptides and
anionic bacterial membranes are a key factor governing the
selectivity ofmany antimicrobial peptides against pathogens. In
contrast to the highly cationic peptides such as defensins,
cyclotides carry only a few cationic residues and normally pos-
sess a net charge of2 or less. Although this may suggest that
the electrostatic effect would play little role in the mechanism
of action, there is a clear correlation between overall charge and
antimicrobial activity. Cyclotides such as kalata B1 and kalata
B2, which carry overall charges of 0 and1, respectively, show
little activity in antibacterial assays, whereas cycloviolacin O2
(2) and hedyotide B1 (3) have low micromolar activity
against several bacteria, including Escherichia coli (25, 26).
Removal of the charges reduces the antimicrobial activity of
cycloviolacin O2 (25), whereas addition of charges to kalata B1
can improve bioactivity (33).
(ii) The surface-exposed hydrophobic patch is ideally suited
for insertion into membranes, and there is some correlation
between the size of the hydrophobic patch and the activity in
hemolytic assays (32, 34). The introduction of positive charges
into the hydrophobic patch of kalata B1 has been shown to
reduce bioactivity (33).
(iii) Recent studies utilizing liposome leakage assays, ellip-
sometry, and surface plasmon resonance techniques using
model membranes with various lipid compositions demon-
strated that both kalata B1 and cycloviolacin O2 have a distinct
preference for membranes containing phosphatidylethano-
lamine (PE) lipids (31, 32). Kalata B1 can also increase the trans-
membrane recruitment of PE lipids from the inner leaflet (31).
An alanine scan of kalata B1 has identified a region centered
around the conservedGlu residue as critical for bioactivity (20).
It was initially speculated that this region was critical for the
self-association of kalata B1 to form membrane pores (20).
However, titrations between kalata B1 and PE head groups
monitored by NMR spectroscopy clearly identify this region as
the site of interaction with PE. A perfect correlation between
biologically inactive Ala mutants of kalata B1 and lack of bind-
ing to PEmembranes demonstrates the importance of this spe-
cific interaction (31). It is possible that other cyclotides may be
selective for other headgroups, allowing the targeting of differ-
ent types of membranes.
The precise mechanism generating membrane leakage by
cyclotides is not entirely clear. Peptide multimer formation
producing a defined pore structure has been suggested based on
stepwise current increase in a patch-clamp experiment (35).
However, the mechanism for the cyclotide cycloviolacin O2
seems to be of amore general character. In this case, the peptide
accumulation results in membrane thinning and curvature
stress (32), which ultimately result in perforations of a more
transient and toroidal character. These types of perforations
are the predominate lytic mechanism for antimicrobial pep-
tides, where defined multimeric pores are rare. For cycloviola-
cin O2, the membrane integrity was also compromised by
selective PE lipid depletion from the membrane by lipid-spe-
cific micellization (32).
Reasons toMake EndsMeet
It is clear that the biosynthesis of the circular proteins
described above must come with an extra cost in terms of
energy for production. So what benefits do they confer to the
organism that express them, and what is the role of these com-
pounds in nature? The arguments in favor for the host defense
theory are convincing. The presence of trypsin inhibitors pro-
tects against herbivores, as do themushroom toxins. In the case
of cyclotides, their insecticidal and antimicrobial effects sup-
port their role in host defense (28). In addition, phytotoxic
activity and activity against soil bacteria have been demon-
strated (36). The fact that cyclotides are expressed in a tissue-
specific manner may be a reflection of the allelopathic role of
cyclotides (37). Transgenic expression of these host defense
proteins may be a potent means of crop protection (38).
The development of circular proteins coincides with the
increasing interest in protein and peptides as drugs. Much of
the attention attracted by circular proteins is due to one of the
advantages they offer, namely their superior stability. They are
thermally, chemically, and biologically stable. The circular
backbone is one component underlying that stability; another
key factor is side chain cross-links (14, 39). As proteins that can
also accommodate a large structural diversity, these com-
pounds have become subjects for protein design.
SFTI-1 is an appealing candidate for drug design because of
its small size. The current drug design applications of SFTI-1
have significance in the field of anticancer therapeutics. For
example, SFTI-1 was engineered to produce a selective inhibi-
tor of KLK4 (Ki  3.59  0.28 nM), a protease associated with
prostate cancer progression (40). Despite being larger than
SFTI-1, cyclotides also are amenable to solid-phase peptide
synthesis (41). Kalata B1 has been successfully grafted to con-
tain anti-angiogenic activity (42), and MCoTI-II to display
activity against foot and mouth virus (43).
In parallel to the chemical approach, an expression system of
recombinant cyclotide libraries has been developed in E. coli
(44) using MCoTI-II as a scaffold. Although only two relative
small libraries were built in that study, proof of concept has
been demonstrated that promises generation of larger libraries
suitable for drug screening in a high throughput manner.
Another approach is to design stable drugs by introducing a
circular backbone into naturally linear proteins. Remarkably,
joining the ends of a conotoxin with a potent analgesic effect
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has been shown not only to increase resistance to proteolysis
and to increase the protein half-life in plasma but also to allow
oral administration (45).
The Never Ending Quest for Circular Proteins
Plants and fungi represent an overwhelming biological diver-
sity. The two kingdoms together contains 2 million species (of
which plants represents 400,000), each of which has its own
unique setup of primary and secondary metabolites. Discovery
of the proteins reviewed here is the result of observations of
bioactivity, followed by targeted searches for analogous com-
pounds. The history of the Amanita toxins dates back to early
history of man and the observations of mushroom poisoning.
SFTI-1 was discovered in a directed search for plant serine pro-
tease inhibitors using affinity chromatography on immobilized
trypsin (7). The first cyclotide, kalata B1, was revealed to be the
active compound in an herbal drug: a decoction of O. affinis
used to accelerate childbirth in certain parts of central Africa
(46).
But howdo you target biodiscovery toward circular proteins?
To determine whether a peptide or protein is cyclic at an early
stage of the discovery process remains a challenge.Modern day
screens for cyclotides utilize their high retention on reversed-
phase HPLC, molecular weight, and cystine content (13).
Recently, genetic information has been used to a larger extent:
screening for cyclotide-encoding RNA has become routine.
The first expressed sequence tag library ofO. affinis revealed 31
cyclotide precursor expressed sequence tags (47). In compari-
son, only 19 cyclotides have been found at the protein level.
Such discrepancies between gene and protein expression are
commonly encountered; for example, cyclotide-like genes have
been found in the Poaceae family, but no protein has been
detected (48). In this context, it should be noted that the infor-
mation from the genome sequencing was the key to uncovering
the ribosomal origin of the Amanita toxins (3). Maybe genome
mining for ribosomal natural products (49) and/or proteomic
approaches based onmass spectrometry (50) will accelerate the
discovery process in the future. It remains a problem that iden-
tification is biased toward compoundswith characteristics sim-
ilar to known compounds, e.g. primers are designed on con-
served sequences, and only certain retention times and masses
are investigated. The protein still needs to be fully sequenced
before definite proof of its cyclic structure can be obtained.
Conclusions
Nature is a proven source for the discovery of new drugs and
new chemical entities. In the currentminireview, we have dem-
onstrated that natural productsmay also play a role in the phar-
maceutical and medical research of today, in which protein-
based drugs become more and more important. It is clear that
plant and fungi are underexplored, and many more diverse cir-
cular proteins await discovery, but the field is mushrooming.
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